Sentence examples for microarray datasets comprise from inspiring English sources
Because microarray datasets comprise tens of thousands of features (genes), they are usually used to test the dimension reduction techniques.
In order to assess whether therapy resistance might underlie the change of the tumor phenotype toward a mesenchymal/basal phenotype, we collected a cohort of 93 microarray datasets comprising murine xenografts of human tumors before and after hormonal therapies.
Underlying GeneFriends is a Mus musculus co-expression map created from 1,678 microarray datasets, comprising over 20,000 individual samples from previously published experiments.
A publicly available Affymetrix microarray dataset comprising ~24,000 genes was downloaded from AtGenExpress.
To investigate the clinical relevance of our observations, we analyzed a microarray dataset comprising 285 primary ovarian cancer patient specimens [ 19].
Expression of cPLA2 α was investigated in a second gene expression microarray dataset comprising 295 breast cancer patients from The Netherland Cancer Institute (van de Vijver et al, 2002).
Recently, we reported in Nagalla et al. [ 36] the discovery of three biologically distinct immune gene signatures, or metagenes, in a large microarray dataset comprising 1,954 breast tumor expression profiles.
Data for many probesets in a given expression microarray dataset are comprised of noise but little or no biological signal.
Four microarray datasets from different institutions comprising 265 advanced stage tumors were uniformly reprocessed into a single training dataset, also adjusting for inter-laboratory variation ("batch-effect").
The dataset samples included in the compendium were grouped into 6 Experiment Sets as follows: 1) Breast Cancer: comprised whole-genome microarray datasets of breast tumors; 2) Normal Breast: comprised whole-genome microarray datasets of normal tissue from invasive ductal or lobular breast carcinomas.
These cohorts comprise available microarray datasets for medically untreated node-negative breast cancer which have used metastasis-free survival (MFS) as an end point.
